ATRO

ASTRONICS CORP
3 filings tracked
industrialsaerospace defenseSMALL ($300M-2B)

Signal Magnitude Chart

BULLISH | 80% | 5/13/2026 | earnings beatBULLISH | 70% | 5/13/2026 | margin expansionBEARISH | 60% | 5/13/2026 | dilution riskBEARISH | 50% | 5/13/2026 | regulatory actionBULLISH | 80% | 5/13/2026 | earnings beatBULLISH | 70% | 5/13/2026 | margin expansionBEARISH | 60% | 5/13/2026 | dilution riskBEARISH | 50% | 5/13/2026 | regulatory actionNEUTRAL | 40% | 5/28/2026 | management changeBEARISH | 60% | 5/28/2026 | dilution riskMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

neutralMay 28

Shareholders elected the Board of Directors with varying levels of support.

management change
40%
bearishMay 28

Adoption of new LTIP and ESPP plans introduces potential equity dilution.

dilution risk
60%
bullishMay 13

Net income surged from $9.5M to $25.5M year-over-year.

earnings beat
80%
bullishMay 13

Gross margin expanded 310 basis points to 32.6%.

margin expansion
70%
bearishMay 13

Significant outstanding convertible notes may lead to share dilution.

dilution risk
60%
bearishMay 13

Ongoing patent infringement litigation with Lufthansa in multiple jurisdictions.

regulatory action
50%
bullishMay 13

Net income surged from $9.5M to $25.5M year-over-year.

earnings beat
80%
bullishMay 13

Gross margin expanded 310 basis points to 32.6%.

margin expansion
70%
bearishMay 13

Significant outstanding convertible notes may lead to share dilution.

dilution risk
60%
bearishMay 13

Ongoing patent infringement litigation with Lufthansa in multiple jurisdictions.

regulatory action
50%

Filing History

8-KMay 28, 2026

The May 28 annual meeting results provide a mixed signal for Astronics investors, balancing structural progress against lingering governance doubts. While the company successfully ratified its board and new compensation frameworks, the presence of millions of broker non-votes and targeted dissent against specific directors indicates that the mandate is not absolute. The immediate impact is a cleared path for management to execute its talent strategy, but the long-term success of these moves will depend on whether the company can deliver margin expansion without excessive dilution.

10-QMay 13, 2026

The Q1 2026 filing presents a company at a crossroads between operational success and financial fragility. On one hand, the top-line growth and backlog expansion indicate that Astronics' products are highly desirable in a recovering aviation market. The successful integration of Envoy Aerospace and Bühler Motor Aviation further expands its capabilities in seat motion and certification, creating a path toward higher-margin aftermarket revenue. However, the sustainability of this growth is questioned by the company's cash flow dynamics and debt structure. The reliance on one-off gains to bolster the bottom line, coupled with a net debt position that puts pressure on credit covenants, suggests that the margin of error for management is slim. Investors must weigh the genuine demand for aerospace technologies against the risks of dilutive convertible notes and the potential for further legal liabilities in the UK and France.